×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Loan Against Mutual Fund
Apply Now
Gold Loan
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Eco Pulse
MC Learn
Elections 2026
Seasonality Analysis
Big Shark Portfolios
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Global Wealth Summit
Unlocking opportunities in Metal and Mining
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
IPL 2026
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
PF
Forum
Videos
you are here:
Home
News
Eli Lilly
Eli Lilly
Lilly’s first weight loss pill wins US nod, to break access barrier
Eli Lilly to buy Centessa Pharmaceuticals for up to $7.8 billion
Nvidia to invest $1 billion in AI drug laboratory with Eli Lilly
Cipla: Emerging markets to lead growth in the near term
How Eli Lilly’s weight-loss drug Mounjaro gained early lead against Novo Nordisk’s Wegovy in India
Eli Lilly's Mounjaro becomes second-most sold drug in September, posts Rs 80 cr revenue: Report
Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
Roche to buy 89bio for up to $3.5 billion in obesity push
Lilly to launch Mounjaro pen in India to compete with Novo's weight-loss drug Wegovy
CDSCO allows Lilly to launch weight-loss drug Mounjaro in pen format
Eli Lilly may manufacture weight-loss drug Mounjaro in India in future, says CEO David Ricks
Global pharma giants Eli Lilly, Novo Nordisk launch obesity awareness campaigns, exploring India market potential
Eli Lilly plans launch of weight-loss drug in emerging markets by 2026, CFO says
Lupin acquires Huminsulin from Eli Lilly to enhance diabetes care portfolio
Divis Lab: GLP-1 opportunity to unfold in the medium term
World Street | Crude oil slumps; Yen drops amid political turmoil; Olympus Corp plunges after CEO drug scandal; and more
World Street | Barnes & Noble founder passes away; Nvidia creates multimillionaires; HBBE rises after ADOR CEO steps down; Bitcoin drops sharply; and more
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
Alphabet taps Eli Lilly Executive as new CFO replacing Porat
Biocon’s formulations business to outpace API share soon: CEO
Open to market Eli Lilly’s weight loss drugs in India: Cipla CEO
Eli Lilly lifts 2024 revenue guidance by $2 billion on weight-loss pills demand
US FDA delays Lilly Alzheimer's drug decision, calls for advisory panel
Eli Lilly could launch obesity drug in India next year, CEO says
World Street | Maersk takes a long cut; mortgages regain appeal; McDonalds faces pressure
View More
Home
Markets
Loans
Gold Loan
News
Portfolio